There are seven production bioreactor systems.
-
Lonza's cGMP manufacturing facility in Slough, UK. -
The facility began production of monoclonal antibodies in 1985. -
The facility successfully passed inspections by all the major regulatory... -
The cGMP manufacturing facility occupies 65,000ft² -
The facility is equipped with laboratories, utilities building infrastructure... -
There are seven production bioreactor systems. -
The facility develops therapeutic grade monoclonal antibodies and recombinant... -
The facility currently operates with approximately 650 employees.
Twitter